Facebook Pixel

Calling Attention to a New Type of Menopause Treatment

By
 
Rate This

Soon after the dawn of the 21st Century, women in Europe had access to a new type of menopause treatment. Since September of 2007, that same treatment has been made available to women of the United States.

It is called “Amberen.” In creating Amberen, scientists found a way to fashion an analogue of the goanadotropin releasing hormone (GnRH). The hypothalamus of a female puts out GnRH when it wants the pituitary gland to release luteinizing hormone and follicle stimulating hormone (FSH).

Amberen contains salts of succinate, the product of a natural biochemical reaction. That reaction takes place at a low level in young pre-adolescent females. When a young girl reaches the age of puberty, then her hypothalamus begins to produce larger amounts of GnRH. Amberen helps to treat the symptoms associated with menopause by stimulating the hypothalamic-pituitary-ovarian axis. That stimulation leads to production of estrogen. An older woman can thus have an estrogen level that mimics the estrogen level in a young pre-menopausal female.

By using Amberen, a woman can counter the physical, biochemical and neurovegetative changes that create problems for many women, as they pass through perimenopause and menopause. This article begins a series of articles about the difficulties experienced by women as they suffer a severe decline in the level of their GNRH, and as they loose their ability to produce estrogen.

Add a Comment3 Comments

Diane Porter

Sue,

Thank you for a very interesting post. Are there certain populations of women who should or should not take Amberen?

And where does Amberen fit in on the continuum of bio-identical hormones and synthetic hormones?

Is it taken with other hormones, like progesterone, or on its own?

I'll be looking forward to reading more!

June 19, 2009 - 8:50am

This Comment

EmpowHER Guest
Anonymous

very nice info at this post... thanks!

June 17, 2009 - 10:52pm

This Comment

EmpowHER Guest
Anonymous

Since Amberen stimulates the hypothalmic/pituitary/ovarian axis, might it be a possible treatment for panhypopituitarism?

March 23, 2009 - 2:53pm

This Comment

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy
Add a Comment
Sue Chehrenegar
View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.

Tags:

Menopause

Get Email Updates

Menopause Guide

Alison Beaver
Empowered

Have a question? We're here to help. Ask the Community.

ASK

Health Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER - for free!